Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Glibemide Forte Glibenclamide and Metformin Hydrochloride Tablets
Glibemide Forte Tablets offer a synergistic approach to diabetes management. By combining Glibenclamide with Metformin, this medication addresses multiple pathways in glucose metabolism, providing comprehensive control over blood sugar levels. This combination is especially useful for patients who require more effective glycemic control than what can be achieved with either medication alone.
Uses of Glibemide Forte Glibenclamide and Metformin Hydrochloride Tablets
Type 2 Diabetes Management: Primarily used to manage blood glucose levels in patients with type 2 diabetes, especially when diet and exercise alone are insufficient.
Combination Therapy: Suitable for patients who have not achieved adequate glycemic control with monotherapy using either glibenclamide or metformin.
Blood Sugar Regulation: Helps in lowering blood glucose levels by improving insulin sensitivity and stimulating insulin secretion.
Preventing Diabetes Complications: Aids in reducing the risk of complications associated with uncontrolled diabetes, such as cardiovascular diseases and nephropathy.
Benefits of Glibemide Forte Glibenclamide and Metformin Hydrochloride Tablets
Enhanced Glycemic Control: Combines two different mechanisms of action to provide more effective blood glucose management.
Reduces Insulin Resistance: Metformin improves insulin sensitivity, while glibenclamide enhances insulin secretion from the pancreas.
Decreases Blood Sugar Levels: Effective in lowering both fasting and postprandial blood glucose levels.
Reduced Risk of Hypoglycemia: Metformin reduces the risk of hypoglycemia compared to sulfonylureas alone.
Comprehensive Therapy: Provides a single-tablet solution for managing blood glucose levels, improving patient adherence to treatment.
Mechanism of Action of Glibemide Forte Glibenclamide and Metformin Hydrochloride Tablets
Glibenclamide is a sulfonylurea that stimulates the pancreas to release more insulin by binding to the sulfonylurea receptor on pancreatic